Generic placeholder image

Anti-Cancer Agents in Medicinal Chemistry


ISSN (Print): 1871-5206
ISSN (Online): 1875-5992

Targeting Inhibitor of Apoptosis Proteins (IAPs) for Cancer Therapy

Author(s): Simone Fulda

Volume 8, Issue 5, 2008

Page: [533 - 539] Pages: 7

DOI: 10.2174/187152008784533107

Price: $65


Since cell death by apoptosis plays a key role in the regulation of tissue homeostasis, dysregulation of the cells intrinsic death program may foster tumor formation and progression. “Inhibitor of apoptosis proteins” (IAPs) block apoptosis at the core of the apoptotic machinery by inhibiting effector caspases. Aberrant expression and/or function of IAPs are found in many human cancers and have been implied in resistance to current treatment approaches. Recent insights into the role of IAPs have provided the basis for various exciting discoveries that aim at modulating expression or function of IAPs. Thus, targeting IAPs, e.g. by antisense approaches or small molecule inhibitors, presents a promising novel approach for future drug development and may proof to be a successful strategy to overcome apoptosis resistance of human cancers.

Keywords: Apoptosis, cancer, IAPs, Smac

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy